Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12 for hypertension alone, 47 for obesity alone, 52 for abnormal tolerance alone, and 124 when all three conditions were present. The prevalence of concentrations (milliequivalents per liter) of erythrocyte Na+ greater than or equal to 7.0, K+ less than 92.5, and plasma K+ greater than or equal to 4.5 in a subsample of 59 individuals with all combinations of abnormal tolerance obesity and hypertension was compared with those in 30 individuals free of these conditions. Altogether, 88.1% of the former vs. 40.0% of the latter group presented at least one of these three markers of internal cation imbalance (P less than 0.001). We conclude that insulin resistance and/or hyperinsulinemia (a) are present in the majority of hypertensives, (b) constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and (c) may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.
M Modan, H Halkin, S Almog, A Lusky, A Eshkol, M Shefi, A Shitrit, Z Fuchs
Year: | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1982 | 1967 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 2 | 3 | 5 | 7 | 15 | 15 | 11 | 14 | 13 | 8 | 15 | 13 | 19 | 117 | 9 | 16 | 19 | 25 | 23 | 18 | 25 | 26 | 25 | 26 | 43 | 38 | 61 | 46 | 42 | 60 | 68 | 81 | 67 | 68 | 38 | 27 | 38 | 21 | 8 | 1 | 1 | 1177 |
Title and authors | Publication | Year |
---|---|---|
ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN HYPERTENSION: METABOLIC SYNDROME REVISITED
AA da Silva, JM do Carmo, X Li, Z Wang, AJ Mouton, JE Hall |
The Canadian journal of cardiology | 2020 |
Increase in oxidized low-density lipoprotein level according to hyperglycemia in patients with cardiovascular disease: A study by structure equation modeling
T Yamada, K Ogawa, TD Tanaka, T Nagoshi, K Minai, T Ogawa, M Kawai, M Yoshimura |
Diabetes Research and Clinical Practice | 2020 |
Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men
AK Kraeuter, R Phillips, Z Sarnyai |
Progress in neuro-psychopharmacology & biological psychiatry | 2020 |
Glucagon-like Peptide-1: Actions and Influence on Pancreatic Hormone Function
Davis EM, Sandoval DA |
Comprehensive Physiology | 2020 |
Impact of sitagliptin combination therapy and hypoglycemia in Japanese patients with type 2 diabetes: a multi-center retrospective observational cohort study
T Saito, H Ohmura, S Nojiri, H Daida |
Journal of Pharmaceutical Health Care and Sciences | 2020 |
Premature birth, low birth weight, small for gestational age and chronic non-communicable diseases in adult life: A systematic review with meta-analysis
EL de Mendonça, M de Lima Macêna, NB Bueno, AC de Oliveira, CS Mello |
Early Human Development | 2020 |
The Impact of Obesity on Tumor Glucose Uptake in Breast and Lung Cancer
BP Leitner, RJ Perry |
2020 | |
Metabolic Syndrome in Children and Adolescents: Is There a Universally Accepted Definition? Does it Matter?
A Serbis, V Giapros, A Galli-Tsinopoulou, E Siomou |
Metabolic Syndrome and Related Disorders | 2020 |
Pioglitazone ameliorates high fat diet-induced hypertension and induces catechol o-methyl transferase expression in rats
M Hegazy, M El-Shafey, AI Abulsoud, BE Elsadek, AI Elaziz, SA Salama |
European Journal of Pharmacology | 2020 |
Commonalities in Management and Husbandry Factors Important for Health and Welfare of Captive Elephants in North America and Thailand
JL Brown, P Bansiddhi, J Khonmee, C Thitaram |
Animals | 2020 |
Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism
YF Lin, KY Peng, CH Chang, YH Hu, VC Wu, SD Chung |
Endocrinology and Metabolism | 2020 |
A Novel Earwax Method to Measure Acute and Chronic Glucose Levels
A Herane-Vives, S Espinoza, R Sandoval, L Ortega, L Alameda, AH Young, D Arnone, A Hayes, J Benöhr |
Diagnostics | 2020 |
Understanding the Molecular Crosstalk in Biological Processes
MA El-Esawi |
2020 | |
Computational model of insulin-glucose regulatory system to represent type 1 diabetes mellitus, hypoglycemia and hyperinsulinemia
AM Ali, FR Tahir |
The European Physical Journal Special Topics | 2020 |
A pilot study to assess the effect of a fibre and mineral formulation on satiety and satiation when taken as part of a calorie restriction diet in overweight and obese women
E Keleszade, T Willner, M Patterson, S Trangmar, S Kolida, A Costabile |
Journal of Functional Foods | 2020 |